HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Rodon Selected Research

Melphalan (Alkeran)

1/2019Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial.
10/2016Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
1/2013Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials.
8/2009Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Rodon Research Topics

Disease

13Multiple Myeloma
01/2022 - 08/2009
2Vomiting
01/2019 - 03/2012
2Venous Thromboembolism
01/2019 - 10/2013
2Neutropenia
02/2018 - 08/2009
2Infections
02/2018 - 01/2018
2Sleepiness
03/2012 - 08/2006
2Peripheral Nervous System Diseases (PNS Diseases)
03/2012 - 08/2009
1Lymphopenia (Lymphocytopenia)
01/2019
1Febrile Neutropenia
01/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Hemorrhage
01/2019
1Thromboembolism
01/2019
1Residual Neoplasm
12/2016
1Disease Progression
10/2016
1Constipation
03/2012
1Nausea
03/2012
1Amyloidosis
03/2008
1Hematologic Neoplasms (Hematological Malignancy)
01/2008
1Neoplasms (Cancer)
01/2008
1Weight Gain
08/2006
1Anemia
08/2006
1Primary Myelofibrosis (Myelosclerosis)
08/2006
1Edema (Dropsy)
08/2006
1Pure Red-Cell Aplasia
05/2003
1Hemolysis
05/2003
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
05/2003
1Cytopenia
05/2003

Drug/Important Bio-Agent (IBA)

7Thalidomide (Thalomid)FDA Link
01/2019 - 08/2006
6Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 02/2015
4Melphalan (Alkeran)FDA LinkGeneric
01/2019 - 08/2009
4Prednisone (Sone)FDA LinkGeneric
01/2019 - 08/2009
3Lenalidomide (CC 5013)FDA Link
01/2021 - 10/2016
2carfilzomibIBA
01/2022 - 01/2019
2Immunomodulating AgentsIBA
01/2019 - 10/2013
2pomalidomideIBA
05/2018 - 02/2015
2Bortezomib (Velcade)FDA Link
01/2016 - 02/2015
1ixazomibIBA
01/2021
1apixabanIBA
01/2019
1EnzymesIBA
01/2019
1Rituximab (Mabthera)FDA Link
02/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1Proteins (Proteins, Gene)FDA Link
12/2016
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2016
1Bendamustine HydrochlorideFDA Link
02/2015
1Immunoglobulin M (IgM)IBA
03/2008
1purineIBA
03/2008
1epoetin betaIBA
01/2008
1fludarabineIBA
05/2003
1Monoclonal AntibodiesIBA
05/2003
1Alemtuzumab (Campath)FDA Link
05/2003

Therapy/Procedure

5Therapeutics
12/2016 - 05/2003
2Stem Cell Transplantation
10/2016 - 01/2016
1Transplantation
01/2013
1Hematopoietic Stem Cell Transplantation
03/2008
1Drug Therapy (Chemotherapy)
01/2008